These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 22768993)
1. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993 [TBL] [Abstract][Full Text] [Related]
2. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918 [TBL] [Abstract][Full Text] [Related]
3. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). Allen J; Donahue B; Mehta M; Miller DC; Rorke LB; Jakacki R; Robertson P; Sposto R; Holmes E; Vezina G; Muraszko K; Puccetti D; Prados M; Chan KW Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1006-11. PubMed ID: 19356859 [TBL] [Abstract][Full Text] [Related]
4. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system. Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848 [TBL] [Abstract][Full Text] [Related]
5. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Merchant TE; Kiehna EN; Li C; Shukla H; Sengupta S; Xiong X; Gajjar A; Mulhern RK Int J Radiat Oncol Biol Phys; 2006 May; 65(1):210-21. PubMed ID: 16472938 [TBL] [Abstract][Full Text] [Related]
6. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332 [TBL] [Abstract][Full Text] [Related]
7. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium. Okada K; Soejima T; Sakamoto H; Hirato J; Hara J Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713 [TBL] [Abstract][Full Text] [Related]
8. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538 [TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Paulino AC Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595 [TBL] [Abstract][Full Text] [Related]
10. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma. Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611 [TBL] [Abstract][Full Text] [Related]
11. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan. Yamasaki K; Okada K; Soejima T; Sakamoto H; Hara J Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362 [TBL] [Abstract][Full Text] [Related]
12. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615 [TBL] [Abstract][Full Text] [Related]
13. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268 [TBL] [Abstract][Full Text] [Related]
14. Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Goldwein JW; Radcliffe J; Johnson J; Moshang T; Packer RJ; Sutton LN; Rorke LB; D'Angio GJ Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):899-904. PubMed ID: 8598368 [TBL] [Abstract][Full Text] [Related]
15. Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. Fouladi M; Chintagumpala M; Ashley D; Kellie S; Gururangan S; Hassall T; Gronewold L; Stewart CF; Wallace D; Broniscer A; Hale GA; Kasow KA; Merchant TE; Morris B; Krasin M; Kun LE; Boyett JM; Gajjar A J Clin Oncol; 2008 Aug; 26(22):3749-55. PubMed ID: 18669462 [TBL] [Abstract][Full Text] [Related]
16. Preirradiation chemotherapy with carboplatin and etoposide in newly diagnosed embryonal pediatric CNS tumors. Heideman RL; Kovnar EH; Kellie SJ; Douglass EC; Gajjar AJ; Walter AW; Langston JA; Jenkins JJ; Li Y; Greenwald C J Clin Oncol; 1995 Sep; 13(9):2247-54. PubMed ID: 7666082 [TBL] [Abstract][Full Text] [Related]
17. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566 [TBL] [Abstract][Full Text] [Related]
18. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review. Ajithkumar T; Avanzo M; Yorke E; Tsang DS; Milano MT; Olch AJ; Merchant TE; Dieckmann K; Mahajan A; Fuji H; Paulino AC; Timmermann B; Marks LB; Bentzen SM; Jackson A; Constine LS Int J Radiat Oncol Biol Phys; 2024 Jun; 119(2):655-668. PubMed ID: 38300187 [TBL] [Abstract][Full Text] [Related]
19. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors. Mizumoto M; Oshiro Y; Pan H; Wang F; Kaste SC; Gajjar A; Chemaitilly W; Merchant TE Pediatr Blood Cancer; 2020 Oct; 67(10):e28617. PubMed ID: 32715632 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study. Wahba HA; Abu-Hegazy M; Wasel Y; Ismail EI; Zidan AS J BUON; 2013; 18(2):425-9. PubMed ID: 23818356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]